Kalo Bios Pharmaceuticals Inc is categorized under in South San Francisco, CA and active since 2000.
Kalo Bios Pharmaceuticals Inc was established in 2000, and today employs 1 to 4, earning Unknown per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 6213400 by the NAICS.
If you are seeking more information, feel free to contact David Pritchard, Chief Executive Officer at the company’s headquarters by writing to 260 East Grand Avenue, South San Francisco, California CA 94080 or by phoning (650) 243-3100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kalo Bios Pharmaceuticals Inc |
| Contact Person: | David Pritchard, Chief Executive Officer |
| Address: | 260 East Grand Avenue, South San Francisco, California 94080 |
| Phone Number: | (650) 243-3100 |
| Website Address: | kalobios.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2000 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 6213400 |
| Share This Business: |
Kalo Bios Pharmaceuticals Inc was started in 2000 to provide professional under the SIC code 2834 and NAICS code 6213400. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact David Pritchard, Chief Executive Officer for inquiries that concern Kalo Bios Pharmaceuticals Inc by calling the company number (650) 243-3100, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Kalo Bios Pharmaceuticals Inc can be found at the coordinates 37.65334,-122.39548 as well as the street address 260 East Grand Avenue in South San Francisco, California 94080.
For its online presence, you may visit Kalo Bios Pharmaceuticals Inc’s website at kalobios.com and engage with its social media outlets through on Twitter and on Facebook.